The results suggest that the L1210 system, using the intratesticular route for inoculation can be used to examine the susceptibility to drugs of leukaemic cells in this environment. The potential of drugs to damage the vascular endothelium of the gonad and perhaps contribute to the development of testicular relapse could be assessed following intramuscular inoculation of cells.
The development of more effective chemotherapeutic agents for the treatment of acute lymphoblastic leukaemia (ALL) about 25 years ago, led to the recognition that increased life expectancy was associated with relapse and signs and symptoms of meningitis, a meningeal syndrome, even during complete haematological remission (Gilbert & Rice, 1957 ). This new phenomenon was shown to be due to invasion of the meninges by malignant lymphoblasts, also present in the cerebrospinal fluid. The circumstances of penetration of meninges and brain by these cells and their relative immunity from drug therapy was thoroughly investigated with particular reference to the routes of invasion and the normal vascular barriers, using both autopsy material and an experimental mouse model, the L1210 leukaemia (Thomas, 1965; Thomas et al., 1962) .
Effective clinical control of meningeal leukaemia was achieved by radiotherapy (Hustu et al., 1973) and during the last ten years cerebral irradiation has become an integral part of the routine treatment of ALL. With the continuing availability of more effective antileukaemic drugs, there has recently been much concern about the increasing manifestation of testicular involvement in the leukaemic process with the implication that this organ could also comprise a protected environment for leukaemic cells from which systemic re-invasion can occur. A survey of the clinical literature has recently appeared (Tiedemann et al., 1982) . Besides the brain .and meninges, the thymus and testis received early mention as possible "pharmacological sanctuaries" (Rall, 1969) , but no supporting experimental evidence for the gonadal site appears to have been published. This paper describes the results of attempts to use the L1210 mouse leukaemia as a model system for the study of testicular relapse in relation to vascular and cellular barriers, in order to investigate the prospects of effective chemotherapy and hopefully avoid therapy by testicular irradiation with permanent destruction of germ cells (Tiedemann et al., 1982 Setchell & Wallace, 1972; Okumura et al., 1975) gives substance to the possibility of achieving a selective chemotherapeutic objective. limb, resulting in a survival time of 7-8 days. Even 2 pd of this same cell suspension intramuscularly resulted in a fatal outcome after 9-11 days so that the number of leukaemic cells injected was obviously far from critical. This small volume was subsequently used for intratesticular injections into the lymphatic sinus system.
Cyclophosphamide (100mg vials of Endoxana) was dissolved in 4ml of sterile water and diluted to give the dosage required in 4mlkg-1, administered I.P.
For histological examination the testes were fixed in Bouins fluid for 24h, followed by 70% ethanol. Other tissues were fixed in 10% formol-saline and all carried through conventional processing to paraffin wax. Sections were cut at 5 pm and stained with haemalum and eosin.
Results and discussion
As is well known, L1210 tumour cells in DBA or BDF1 mice are highly malignant, irrespective of route of injection, with 100% lethal outcome in 7-10 days, depending on the number of cells inoculated. The cause of the acute death seems not to have been established so far as biochemical parameters in the BDF1 mouse are concerned. Subsequent to i.m. inoculation, a locally invasive tumour develops (Figure 1 ) accompanied by extensive systemic involvement of bone marrow and spleen with a variable degree of infiltration of liver and kidney (Figure 2) . No indication could be found of invasion of testicular or epididymal interstitium even in the terminal phase ( Figure 3 ) although there was evidence of leukaemic cells in the testicular blood vessels. In view of the rapid progression of the disease there could have been inadequate time for leukaemic cells to penetrate these, especially in view of the reputed "tight" junctions between the vascular endothelial cells. Nevertheless the testicular capillary wall is known to be readily crossed by many substances, including iodinated albumin, so reaching testicular lymph (Setchell et al., 1969) . Only in the ascitic form of the leukaemia, produced by i.p. inoculation of cells, was invasion of part of the epididymis and vas deferens seen (Figure 4 ) but the testis remained clear.
As with the testis and epididymis of mice bearing the L1210 leukaemia, we found no indication of infiltration of meninges or cerebral tissue as has been previously reported. Methotrexate treatment in the advanced stage of the disease could produce a twofold increase in lifespan (Thomas et al., 1964) , in which case meningeal leukaemia developed. Actual invasion of cerebral tissue was not a feature.
Progressive growth and infiltration occurred in both dura and arachnoid during treatment with methotrexate. After intracerebral inoculation with L1210 cells the suggestion was that spread to extracranial organs occurred by the haematogenous route or direct extensions outwards through tissues surrounding cranial and spinal nerves and blood vessels (Thomas et al., 1962 ). Cyclophosphamide (s.c.) prolonged the mean survival time in such mice by completely destroying the leukaemic cells in liver, spleen, bone marrow and dura, whereas those in the subarachnoid space continued to proliferate. A "therapeutic barrier" was referred to where the systemic effect of cyclophosphamide ceased "so far as intracranial tissues are concerned", because insufficient drug passed the blood-brain and cerebrospinal-blood barriers.
Thus the situation in the brain and meninges is more complex than in the testis. In the latter organ are two barrier components. The drug-permeable vascular bed is surrounded in mouse and rat by a lymph sinusoidal network containing groups of Leydig cells. The lymph bathes the seminiferous tubules, the walls of which comprise a combination of myoid and Sertoli cells, most of the cytoplasm of the latter cells lying within the tubules (Fawcett, et al., 1973 ).
In the current work, the possibility of a testicular environment unfavourable to L1210 cell growth was eliminated by intratesticular injection of cells into the lymphatic sinusoidal system (2,ul containing about 5 x 103 cells). Rapid peritubular cell-growth followed, associated with testicular enlargement. The seminiferous tubules did not appear to be directly invaded but rather destroyed by a process of attrition (Figures 5 and 6 ). The overall picture closely resembled that seen in children with ALL. There was, too, a rapid systematic spread from the testis resulting in death at times comparable to those following injection of the same number of tumour cells by the intramuscular route. The contralateral testis was not invaded.
Extension of the survival time was achieved using single doses of cyclophosphamide. The ED50 for the drug was determined using an i.p. injection administered on day 3 post-inoculation (i.m.) of L1210 cells, with 10 mice per group. There was one long-term survivor at 30mgkg-1, whilst doses of 60, 80 and 90mg kg-1 yielded 50% surviving beyond 9-12 months. Doses of 100mgkg-1 and upwards resulted in 100% survival. Dose-response studies had been reported by Goldin (1969) with the L1210 leukaemic in BDF1 mice but using 107 cells per inoculum subcutaneously. Cyclophosphamide was also injected s.c. on day 3 and survival assessed up to 60 days. There were no survivors up to 120mgkg-1, and only 50% between doses of 245 and 350mgkg-1, after which the toxicity of the drug itself operated so that no animals survived at 500mg kg-1. More recently using the same leukaemia in DBA mice with an i.p. inoculation of 3 x 106 cells from the ascitic form of the disease, no therapeutic effect was observed with cyclophosphamide (50mgkg-1i.p.) given on day 1 and repeated on day 8 (Page et al., 1977) . The difference between these results and the high cure rate in the present work is presumably related to the size of inoculum and/or route of administration of the cyclophosphamide (Goldin, 1969) . However, in the current series, the onset of relapse was associated with the development of local tumour at the original site of inoculation, but its presence did not seem to herald the usual rapid systematic dissemination of the leukaemia. A number of such animals (6) were examined in the period of relapse, again with no evidence of testicular involvement, although leukaemic infiltration occurred in spleen, liver and kidney. Cell suspensions from the local tumours did produce the characteristic, rapidly progressive disease. It seemed therefore, that damage to the vascular endothelium within the testis was a requisite for testicular invasion in this mouse model. Evidence was first sought by local irradiation of the gonads (10 Gy, linear accelerator) followed by i.m. inoculation with L1210 cells after 24h or 7 days, but in neither instance did testicular invasion occur. The cadmium ion is well known to damage the vascular endothelium of the testis in scrotal mammals (Waites & Setchell, 1966; Hark6nen & Kormano, 1970) . We first carried out dose-response studies in BDF1 mice which showed that whereas a dose of 0.01 mM of aqueous cadmium chloride (-3 mg kg-1) produced extensive testicular damage, 0.005mM was ineffective. Inoculation with L1210 cells one week after the higher dose of cadmium salt did lead to distinct focal infiltration of the interstitium (Figures 7 & 8) , with the implication that damage to the capillary endothelium was a prior requisite to penetration by L1210 cells. It is interesting that the leukaemic cells were still unable to penetrate the wall of the damaged seminiferous tubules.
The direct use of the L1210 mouse model for the study of testicular relapse is thus deficient because of the inability of circulating malignant lymphoblasts to penetrate the vascular endothelium within the testis. However, there is a distinct possibility that therapeutic agents alone or in combination may damage the vascular endothelium and thus facilitate testicular invasion and promote testicular relapse. This may be relevant to the varied incidence of testicular relapse in different centres of treatment (Tiedemann et al., 1982) . The L1210 mouse model might still provide a useful test system for discerning such potential, so that histological examination of the testis and epididymis using this leukaemia could be applied to screening procedures for new drugs; an examination of those currently in therapeutic use might well be worthwhile.
